Latest Deals

Credit: 

EDP Biotech announced an asset merger with New Day Diagnostics to form a vertically integrated diagnostic company to advance development and commercialisation of diagnostic tests. The merged company will operate as New Day Diagnostics.  

The company said it will address multiple indications by leveraging the combined development capabilities, strategic partnerships and distribution channels. EDP offers an in vitro diagnostic assay called ColoPlex, which helps identify pre-cancerous cancer polyps and colorectal cancer early. 

Medical device company Biocomposites has acquired a minority stake in UK-based Renovos Biologics, for an undisclosed sum. Renovos has developed a synthetic, biodegradable nanoclay carrier called RENOVITE, which intends to place several pharmaceutical drugs and biologics at the treatment site. As a cell-responsive carrier, it expedites healing with a reduced dose of the therapeutic drug. 

A company using eye-tracking technology combined with deep learning to provide a ‘unique window to the brain’ has secured €3m ($3.2m) to help develop the technology. Deeptech startup Reyedar aims to create a quick and non-invasive method to test early for degenerative diseases such as glaucoma, Parkinson’s disease, and multiple sclerosis.

Diagnostics company Novacyt UK has agreed to purchase UK-based genomic medicine company Yourgene Health in a £16.7m ($21.3m) deal. The deal is expected to close in September 2023. Following the news, Yourgene Health shares listed on the London Stock Exchange opened 103% higher compared to the pre-announcement market close (29 June). The company has a current market cap of £15.4m.